|
|
|
Issue Open Date
|
30-Jul-24
|
|
|
|
Issue Closing Date
|
01-Aug-24
|
|
|
|
Application Money
|
100
|
|
|
|
Allotment Money
|
|
|
|
|
|
|
|
Price Band
|
646
-
679
|
|
|
|
Minimium Application No.
|
22
|
|
|
|
Issue Size (Shares)
|
27368151
|
|
|
|
Market Lot
|
1
|
|
|
|
|
|
|
Objective
|
|
a. Repayment/ prepayment of indebtedness of our Company;b. Repayment/ prepayment of indebtedness of our Subsidiaries namely, Maxcure Nutravedics Limited and Pure and Cure Healthcare Private Limited;c. Funding incremental working capital requirements of our Company;d. Pursuing inorganic growth initiatives through acquisitions; ande. General corporate purposes.
|
|
|
|
|
|
|
Category
|
No. of Shares
|
No. of Shares
|
Subscription Ratio
|
|
|
Offered / Reserved |
Bid For |
|
|
Non-Institutional Investors
|
4068637
|
171750128
|
42.2131853984516
|
|
Qualified Institutional Buyers
|
8137276
|
733117770
|
90.0937574195591
|
|
Retail Individual Investors
|
8137276
|
733117770
|
90.0937574195591
|
|
|
|
|
Business Description:
Established in 2004, we are a pharmaceutical contract development and manufacturing organization (“CDMO”) offering a comprehensive range of pharmaceutical products and services in India and overseas. As one of the leading CDMOs in India, we own the intellectual property for the manufacturing processes of several of our formulations, and our core business is focused on providing end-to-end product development and manufacturing solutions to our clients. Some of our other services include formulation research and development (“R&D”), preparation and filing of regulatory dossiers in the Indian and global markets, and other testing services. In addition to our core CDMO business, we are also engaged in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (“APIs”).
|
|
|
Promoter's Holding
|
|
|
|
Total Share Capital
|
121528880
|
|
|
|
Offered to Public
|
27368151
|
|
|
|
Promoter's Holding (Pre-Issue)
|
82.48
|
|
|
|
Promoter's Holding (Post-Issue)
|
75.26
|
|
|
|
|
|
|
|
|
|
|
|
Address |
304 Mohan Place
L S C
Saraswati Vihar
Delhi
,
Delhi
,
110034
Phone :
011- 69041000
Email :
cs@akums.net
Website :
www.akums.in
|
|
|
|
Registrar |
Link Intime India Pvt Ltd.
C 101
247 Park
LBS Marg
Vikhroli (West)
Mumbai
|
|
|
|
Listed at |
|
BSE, NSE
|
|
|
|
Lead Manager |
Ambit Pvt Ltd.
Axis Capital Ltd.
Citigroup Global Markets India Pvt Ltd.
ICICI Securities Ltd
|
|
|
|
Promoters |
Akums Master Trust
Sandeep Jain
Sanjeev Jain
|
|
